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Introduction 
Reticulocytes are immature red blood cells, which
contain intracellular Ribonucleic acid (RNA), Mitochondria
and Ribosomes.1 The significance of reticulocyte count in the
diagnosis of anaemia cannot be underestimated as it provides
vital information about the classification and pathogenesis of
anaemia.2 Reticulocyte count is the index of erythropoietic
activity within bone marrow.3 Hence, reticulocytosis would
depict increased erythropoiesis in response to various clinical
scenarios like blood loss, haemolysis or post successful
therapy in iron, vitamin B12 or folate deficiency states.
Similarly, conditions such as untreated nutritional anaemia or
bone marrow failure would suppress red cell production and
thus the reticulocyte count.4 Enumeration of reticulocytes can
aid in monitoring the response of erythropoietin therapy in
chronic renal failure5 and may also herald post chemotherapy
or transplant marrow recovery in aplastic anaemia or
malignant disease.6 Traditionally, reticulocyte quantification
had relied upon microscopic techniques but recently
automated reticulocyte analysis has become widely available.
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Abstract
Objectives: To establish the credibility of manual reticulocyte counts without compromising the quality of care,
and to evaluate the degree of acceptability of manual reticulocyte counts in terms of accuracy and cost
effectiveness in comparison with two automated haematology analyzers. 
Methods: Visual reticulocyte enumeration was evaluated for comparability, within-batch precision and costing
with respect to Coulter® STKS and Gen S haematology analyzers. 
Results: The results of reticulocyte estimation for 80 samples as obtained by 3 modes were correlated using
Pearson's correlation coefficient (r) which were computed as 0.884 , 0.875, and 0.793 for manual-Gen.S, Gen.S-
STKS and manual-STKS respectively thus showing positive association of these results. STKS had the CV of
10.4% and was more precise compared to Coulter® Gen.S (CV=11.6%) while manual counts showed the least
precision with a CV of 19.8%. The cost per test was calculated to be $ 0.11 for manual technique in contrast to
$0.45 for Gen S and $1.09 for STKS.
Conclusion: Visual counting of reticulocytes can be used as a reliable tool for estimating reticulocytes in
resource strained countries as it is not only cost effective but can also efficiently discriminate between high and
low reticulocyte ranges which are required for sound clinical judgment (JPMA 60:892; 2010).
However, in countries like Pakistan, manual technique is still
the most common procedure utilizing a trained microscopist
and supra-vital stains like methyelene blue. Although
relatively simple, it is flawed with 25-50% inter-observer
variation.7-9 The reason may be multi-factorial; like reliance
upon the expertise of a technical observer, the use of ocular
inset and the homogeneous distribution of reticulocytes in a
well spread film and the number of cells counted.10
The manual reticulocyte count though inexpensive is
tedious and shows low reproducibility. Introduction of
automated technologies have greatly increased the accuracy
and precision of reticulocyte count with the coefficient of
variation (CV) of 3-12.3%.11 Based on the principle of
flowcytometry, reticulocytes are estimated after staining with
fluorescent (thiazole orange, auramin-O, cyanene) or non
fluorescent (Oxazine 750, new methylene blue) dyes12 which
precipitate residual RNA while an acidic reagent clears
haemoglobin. Usually 32,000 red cells are counted and
assayed by volume, conductivity and light scatter (VCS).
With introduction of maturation indices and volume
measurements, automated reticulocyte counting provides a
new and meaningful approach to this analysis.13 The
inclusion of these parameters has shown promising results for
diagnostic and therapeutic purpose.14-16 Moreover, the initial
expense of automated instruments and their reagents is offset
by reduction in time consumption, making them an attractive
cost effective option.17 The presence of Howell jolly bodies,
red cells fragments, plasmodia, nucleated red cells, siderotic
inclusions, cell debris, large platelets and platelet clumps in
the samples, interferes with the proper enumeration of
reticulocytes.18
In developing and under resourced countries,
automation cannot be offered in most laboratories especially
in a rural setting. Therefore, the present study was designed
with the aim to evaluate the manual reticulocyte counting
with two haematology analyzers Coulter® STKS and Gen S
in terms of accuracy, precision and cost effectiveness. 
Material and Methods 
The study analyzed 80 unselected samples (from 50
adults and 30 children) for which reticulocyte count was
requested during March 1 - March 31, 2007 at the clinical
laboratories of Aga Khan University Hospital. The adults' age
range was 15 to 85 years (median 40 years) and paediatric
population age range was 0.0 (newborn) to 10 years (median
0.02 years). All samples sent for reticulocyte counting during
this study period were included, to ensure sufficient samples
in higher values outside the reference range to validate the
results. The samples were divided into 2 groups A and B
corresponding to reticulocyte range of 0-2, 2.1 and above
respectively. The reason for this grouping was our population
based reference range which was 0.2-2.0% for adults and
children aged 2-12 years.
Five ml of blood was collected in vacutainer
containing K3-EDTA (Becton Dickinson) after informed
consent and were kept at room temperature throughout
testing and analyzed within 6 hours of collection.
Reticulocyte analysis of each sample was done through visual
technique and by two instruments Coulter® STKS and
Coulter® Gen.S (Coulter electronics, Hialeah, Fl, USA). 
Briefly, manual counting was performed by mixing 50
µl of new methyelene blue (Sigma-Aldrich®, Germany) with
100 µl of blood sample in a test tube and after 10 minutes of
incubation at room temperature, and remixing, a thin smear
was prepared. One thousand red cells were counted on each
smear of all samples. The percentage of cells containing
stained RNA was recorded microscopically through
Olympus® BX51 (Japan) by two independent observers who
examined all 80 cases individually to minimize subjective
variation. The ocular inset was not utilized.
Coulter® STKS is a semi automated while Coulter®
Gen.S is a fully automated system. The instruments were
used according to manufacturer's instructions and all results
were recorded in percentage as our clinicians are more
familiar with these values.All instruments were calibrated
according to the manufacturer's instructions. Daily start up
and shut down procedures were performed as well as all
recommended quality control (Coulter® Retic-CTM Cell
control, Beckman Coulter, Inc., USA) was run on both
instruments on daily basis.
Within batch precision was determined on 5 different
routine samples by analyzing each of them, 10 times
repeatedly on both instruments. As for the manual method, 10
slides were prepared from each sample and observed by 2
independent observers. The results were expressed as a mean
of the two observer readings.
The cost per test for each mode was estimated by
adding labour cost to the expense of the reticulocyte reagent
used. The latter was calculated by noting the reagent
consumption for a period of a month and dividing the volume
by the number of tests performed over the period. The cost of
equipment was disregarded as these are already established
instruments in the clinical lab.
Statistical Analysis
All statistical analysis was done using SPSS version
14.0 (SPSS, Chicago, IL, USA) and Med Calc® (Med Calc
software version 9.6.3.0, Mariakerke, Belgium). Descriptive
statistics including mean (± standard deviation) for
quantitative variable were used. Linear relationship and the
distribution of reticulocyte measurements by three
methodologies were studied through scatter-plot and
histogram and were found to be normal. Pearson correlation
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coefficient (r) was utilized for determining the strength of
linear association between various results for groups A
(reticulocyte count 0-2%) and B (counts 2.1% and above)
separately. The threshold for significance was 0.05 for two-
tailed test. Bland and Altman plots19 were used to calculate
mean difference (bias) and agreement between three
methodologies; it was considered that 95% of all values
lying within ±2SD indicate good agreement. When
comparing a test method against reference method, it is
important to interpret that the two can be used
interchangeably if there is no random, absolute or
proportional bias between the two. Random error can be
estimated through correlation coefficient (r). The absolute
(or constant) and proportional errors are defined respectively
as fixed, and percentage change, in results given by test
method when compared with reference method. These can
be analyzed utilizing linear regression models such as
Passing and Bablok.20 This equation states that there is no
statistical difference between reference and test method if
respective confidence intervals include a slope of (B) 1 and
intercept (A) of zero indicating absence of absolute and
proportional bias respectively.
Results
During the study period, 80 samples were collected
from 44 (55%) males and 36 (45%) females. The ages of
these patients showed considerable heterogeneity ranging
from 0.0 (newborn) to 85 years (median 23 years). Manual
reticulocyte results ranged from 0.2 to 12.7%, while
automated results from Gen.S and STKS ranged from 0.46
to 14.5 and 0.1 to 16.6% respectively.
Reticulocyte counts (mean ± 1.0 SD) were 2.7 ±
2.4% and 2.6 ± 1.88% by STKS and Gen.S respectively.
Manual method gave marginally lower results at 2.4% ±
2.07%.
The results of reticulocyte estimation obtained by 3
modes were correlated using Pearson's correlation
coefficient (r). These were computed as 0.884 (p=0.000),
0.875, (p=0.000) and 0.793 (p=0.000) for manual-Gen.S,
Gen.S-STKS and manual-STKS respectively thus showing
positive association of these results. Group A (reticulocyte
count <2.0 %) and group B (reticulocyte count >2.1%) also
showed similar linear association for the reticulocyte
estimations by the three techniques (Table-1).
Regression equations (calculated by Passing and
Bablok) along with the calculated values for groups A and
B are summarized in Table-2. Absolute bias was seen in
STKS against both manual and Gen.S while proportional
bias was seen in manual counting vs. automation in group
A. However, in group B, Visual counting and GenS showed
good correlation, however both intercepts and slopes were
observed in manual vs. STKS and Gen.S vs. STKS. An
inter-method bias was observed as reticulocyte percentage
was consistently higher on GenS compared to visual
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Figure: Difference against average of Visual and Gen.S measurements, with 95%
limits of agreement (broken line) and regression line.
Table-1: Correlation Coefficient for reticulocyte enumeration
(Groups A & B) through visual technique, Coulter Gen.S and
Coulter STKS.
Group A (n=40) Manual-Gen S Manual- STKS Gen S-STKS
r 0.698 0.562 0.5770
P-value <0.0001* 0.0002* 0.0001*
95%CI 0.494-0.829 0.304-0.734 0.324-0.753
Group B (n=40) Manual-Gen S Manual- STKS Gen S-STKS
r 0.841 0.704 0.850
P-value <0.0001* <0.0001* <0.0001*
95%CI 0.717-0.913 0.503-0.833 0.732-0.918
* Statistically significant P-value.
Where r=coefficient of correlation and CI = confidence interval.
Table-2: Comparison of three techniques using Passing and Bablok
equation.
Group A Manual-Gen S Manual-STKS GenS-STKS
Intercept A 0.18 0.62 0.57
95%CI -0.13 to 0.42 (=0) 0.38 to 0.81 0.29 to 0.8
Slope B 0.61 0.43 0.76
95%CI 0.44 to 0.83 0.28 to 0.63 0.48 to 1.06
(=1)
Group B Manual-Gen S Manual-STKS GenS-STKS
Intercept A -0.50 1.12 1.38
95%CI -1.86 to 0.38 (=0) 0.25 to 1.77 0.66 to 1.86 
Slope B 1.25 0.59 0.53
95%CI 0.85 to 1.58 (=1) 0.38 to 0.86 0.39 to 0.71
The remarks (=0) or (=1) are added for where 95% confidence interval for intercept
A or slope B equals 0 or 1 respectively for absolute and proportional bias.
counting (Figure) and on STKS than Gen.S. This was
particularly evident when percentage of reticulocyte count
was < 5. No inter-method bias was observed in visual and
STKS results.
In batch precision of investigated methods was
tested by serial measurements of 5 routine samples 10
times. We found that STKS had the CV of 10.44% and was
more precise compared to Coulter® Gen.S (CV=11.68%).
Inter-assay precision of the visual count was determined
by preparing 10 separate blood films from one sample.
Mean reticulocyte count was 2.6±0.53 and as expected
showed least precision in comparison to automation with a
CV of 19.85% 
The cost per test was calculated to be $ 0.11 for
manual technique in contrast to $0.45 for Gen S and $1.09
for STKS.
Discussion
Reticulocyte enumeration is an important indicator
of bone marrow erythropoiesis3 which is required by
clinicians in a number of clinical situations.2 Because of its
diagnostic and therapeutic implications; it is usually the
most commonly requested test in the evaluation of
anaemia.4 Visual reticulocyte counting is a widely utilized
and accepted test in our laboratories, as it is highly cost
effective in comparison to automation. However, a number
of studies have shown this technique to be time intense,
tedious, inaccurate as well as imprecise when compared
with automation.10 The present study was undertaken to
compare visual counting with automation in order to assess
the feasibility of various methodologies in Pakistan.
The study showed a high degree of correlation
between visual counting and automation similar to
previously reported results.21 However, such positive
association between manual and automation techniques has
been denied by others.22 It is interesting to note that the
results are comparable to those studies that have used
similar Coulter®systems as used here. Perhaps the
difference in visual counting and automation may be
attributable to various haematology analyzers utilized in
various studies.
It was observed that the three techniques were
positively correlated in lower count as well as at higher
reticulocyte counts with statistically significant results.
Coulter® STKS gave 5 unreliable high counts compared to
other two techniques. Our study did not address
specifically the cause of this discrepancy, but it is well
known that interference factors like nucleated red cells,
Howell Jolly bodies, or other red cell inclusions as well as
haemoglobinopathies or high white cell count can result in
such erroneous results.8,23 It has been suggested that such
implausible results should be counterchecked through
differential counts and or manual reticulocyte counting.24
The results analyzed through the three techniques showed
good agreement as majority of results lie within 95% limits
of confidence interval. It was also generally observed that
such correlations became weak with the increase in
difference in measurements. Also, reticulocyte analysis by
STKS was consistently higher compared to results by
visual and Gen.S.
In batch variability was determined in routine
samples by all three methods. The obtained CV values
were between 10.4-11.7 % for 2 automations. The fine
precision of automated counting has been observed in
numerous previous studies evaluating various
haematology analyzers.24,25 In CAP reticulocyte project
report, it was recommended that for an automated system
r-value should be greater than 0.95 and CV should be 15%
or less.7 The automated reticulocyte count evaluated in
our study met this criterion of CV. Visual counting
showed less reproducible and more variable results with a
CV of 19.85%. Such results were not unexpected as they
have been described before.7,10 The reason for this
variability may be due to sample staining, because of less
number of cells being counted compared to automation,
inaccurate identification of reticulocytes, non uniform
distribution on smear, or differences in technologists'
experiences in visual counting.25 It has been observed that
inconsistent microscopy rather than sample staining is the
single most important factor responsible for this
inaccuracy.21 To overcome this inherent problem
associated with visual counting, we utilized 2
microscopists with different experiences and the results
were expressed as average of their counts.
When one compares the cost of manual counting vs.
automation in our setting, it is usually the former which is
least expensive as seen in our study also. The reason may be
partly because of low labour cost in our country in
comparison to automation which requires expensive
imported consumables. This is in sharp contrast to reports
from developed countries where instrumentation has been
described to be more cost effective. 
The present study indicated that manual reticulocyte
counting is more cost effective but less precise. A linear
relationship with respect to automations was observed at
lower as well as higher reticulocyte counts. Hence, visual
technique can aid in the interpretation of clinical cases and
therefore would facilitate a clinician's judgment which will
not be any different from the one made on the basis of
automated results. 
The present study was evaluated to have certain
limitations in terms of lack of clinical details, and not
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analyzing the various techniques for linearity, carry over,
stability of reagents and between-batch precision.
However, we feel that our study in spite of limitations
sufficed our purpose. 
Hence, automated techniques owing to its higher
cost should be limited to clinical laboratories associated
with tertiary care hospitals. Small laboratories in urban
areas and those in rural setting can perform visual
reticulocyte counting with considerable degree of
confidence. This will be economical for them as well as cost
effective from a patient's point of view. However, in patients
where the results do not correlate clinically, reticulocyte
analysis should be done by automation. This can easily be
achieved by sending them to larger clinical laboratories that
can act as a referral centre for them.
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